Cost-Utility Analysis of Dimethyl Fumarate as a First Switch Treatment for Relapsing Remitting Multiple Sclerosis in the Brazilian Public Health Care System
May 1, 2016, 00:00
10.1016/j.jval.2016.03.192
https://www.valueinhealthjournal.com/article/S1098-3015(16)00260-6/fulltext
Title :
Cost-Utility Analysis of Dimethyl Fumarate as a First Switch Treatment for Relapsing Remitting Multiple Sclerosis in the Brazilian Public Health Care System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00260-6&doi=10.1016/j.jval.2016.03.192
First page :
A61
Section Title :
Neurological Disorders - Cost Studies
Open access? :
No
Section Order :
1526